查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1848743

膜式氧合器市場按類型、應用、最終用戶、材料、流量配置和溫度分類 - 全球預測 2025-2032

Membrane Oxygenators Market by Type, Application, End User, Material, Flow Configuration, Temperature - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，膜式氧合器市場規模將達到 11.1433 億美元，年複合成長率為 6.77%。

關鍵市場統計數據
基準年 2024 6.5981億美元
預計年份：2025年 7.0416億美元
預測年份 2032 11.1433億美元
複合年成長率 (%) 6.77%

為膜式氧合器提供全面的發展方向，重點關注臨床需求、技術支援、監管壓力以及產業相關人員的策略重點。

膜式氧合器是體外生命維持和外科灌注的基石技術，作為血液氣體交換介面，在心肺體外迴圈）過程中維持氧合和二氧化碳清除。其設計、材質以及與監測系統的整合不僅決定了其臨床性能，還決定了其在重症監護環境下的可處置性、生物相容性和易用性。隨著臨床實務朝向更複雜的重症加護應用和門診外科介入發展，氧合器的可靠性和可預測性對患者預後仍然至關重要。

臨床醫師越來越傾向選擇兼顧生理性能和操作效率的醫療器材。這促使膜幾何、纖維製造和表面化學技術同步發展，旨在降低溶血、補體活化和血栓形成風險，同時維持較低的跨膜壓力梯度。同時，監管機構對一次性醫療器材、無菌驗證和人因工程的要求也促使產品研發更加重視關鍵環節。綜上所述，這些技術和臨床促進因素構成了本執行摘要的其餘部分，並為製造、採購和臨床應用等各環節的策略決策奠定了基礎。

材料創新、設備小型化、數位整合和臨床護理分散化如何重新定義膜式氧氣療法的設計、製造和採購標準

在臨床需求、材料科學和系統整合的推動下，膜式氧合器領域正經歷著變革性的轉變。中空纖維結構結合先進的聚甲基戊烯膜和精密的表面塗層，已取代以往的平板式結構，成為高性能體外循環支援的理想選擇，顯著提高了氣體交換效率和血液相容性。同時，製造流程和滅菌技術的進步，使得一次性氧合器的規模化生產成為可能，不僅滿足了嚴格的無菌性和可追溯性要求，也簡化了手術室的物流。

同時，這些醫療設備的臨床應用環境正變得日益分散。體外膜氧合（ECMO）在非傳統醫療環境中的日益普及、進行複雜手術的門診手術中心不斷擴張，以及對模擬和照護現場診斷的日益依賴，都促使市場需求轉向更模組化、更易於使用且整合監測功能的設備。數位醫療技術的整合，包括即時感測器遠端檢測和決策支援演算法，正在提升臨床醫生調整治療方案和預防併發症的能力。雖然永續性已不再是首要考慮因素，但其重要性卻與日俱增，製造商們正在評估產品生命週期的影響，並探索可回收包裝、減少材料用量和減少生產廢棄物等方法。這些轉變共同重塑了產品開發藍圖、市場推廣策略以及買家評估產品價值的標準。

分析2025年美國預期關稅調整對膜式氧合器相關人員的供應鏈、採購和創新的累積影響

美國預計2025年的貿易政策變化和關稅調整將對膜式氧合器的供應鏈、籌資策略和定價動態產生重大影響。許多氧合器組件和高精度製造投入都來自跨境供應鏈，進口原料、聚合物樹脂或成品的關稅增加可能會提高製造商和下游買家的到岸成本。此類變化往往會促使供應商和原始設備製造商（OEM）重新評估籌資策略策略，加快對國內或近岸合作夥伴的供應商資質認證，並考慮建立本地庫存緩衝，以在貿易環境波動的情況下維持供應的連續性。

關稅帶來的成本壓力累積效應通常表現為新產品上市延遲和短期內更保守的庫存管理，因為製造商優先考慮利潤率保護和供應安全。一些緩解策略是可行的：例如，實現供應商；尋找既能保持臨床性能又能改善關稅待遇的替代材料；以及在關稅優惠地區實施製造外包安排。對於供應商，更長的採購前置作業時間和重新評估的總擁有成本計算要求他們更加重視供應商的透明度和協作預測。最終，貿易政策正在加速企業在垂直整合、供應商合作和設計選擇方面的策略決策，這些決策能夠在維持臨床績效標準的同時降低進口關稅的風險。

主導細分市場的洞察揭示了設備架構、臨床應用、終端用戶需求、材料科學、流動配置和熱處理通訊協定如何相互交織，從而指導產品策略。

深入的市場區隔揭示了產品特性、臨床應用案例和組織採購優先順序如何交織，共同塑造需求和創新路徑。平板式設計在特定的實驗室研究和特殊低流量應用場景中保持著獨特的適用性，而中空纖維結構則在臨床體外應用中佔據主導地位，因為在這些應用中，表面積體積比和緊湊的外形規格至關重要。依應用領域分類，本文探討了血液氧合（研究）、心肺體外迴圈和體外膜氧合（ECMO）的應用。心肺體外迴圈也進一步擴展到冠狀動脈繞道手術繞道手術和瓣膜置換術，這兩種手術都呈現出不同的灌注時間曲線和抗凝血管理挑戰。

終端用戶細分揭示了不同的採購促進因素。門診手術中心、醫院和研究機構分別從成本效益、臨床穩健性和實驗靈活性三個方面評估氧氣輸送裝置。按材料分類，目前正在研究聚甲基戊烯、聚丙烯和聚碸，其中聚甲基戊烯因其優異的氣體滲透性和熱穩定性，在長期體外支持方面越來越受歡迎。流動配置分析考慮了封閉式和開放式系統。閉合迴路設計優先考慮感染控制和精確的氣體交換控制，而開放式配置則優先考慮特定手術流程中的簡單性和易用性。基於溫度的細分考察了低溫和常溫應用場景，認知到膜性能和血液相容性可能隨溫度變化而變化，並且安裝驗證必須解決這些臨床方案之間的生物物理差異。總而言之，這些細分視角為設計權衡、監管策略和有針對性的商業化方法提供了基礎。

區域臨床應用、監管差異和生產能力決定了美洲、歐洲、中東和非洲以及亞太地區膜式氧合器業務的差異化策略。

區域差異對臨床實踐、監管路徑和採購框架的影響，對製造商和醫療保健系統都至關重要。在美洲，體外療法的臨床應用受到以下因素的影響：集中化的體外治療卓越中心、強調上市後監測和器械可追溯性的法規環境，以及兼顧國內生產和戰略進口的供應鏈。這些動態為那些能夠展示可靠的臨床數據、可擴展的生產能力和靈活的服務模式的公司創造了機會。

在歐洲、中東和非洲，監管環境複雜多樣，各國在努力協調監管環境的同時，採購規範也各不相同，報銷政策和醫院競標流程也存在差異，因此需要靈活的商業化模式和強大的臨床營運支援。本地製造夥伴關係和分銷商關係往往決定產品上市的速度。在亞太地區，部分都市區的臨床應用正在快速普及，這催生了一批又一批本地製造商和委託製造製造商，他們能夠在前置作業時間和成本方面展開競爭。戰略夥伴關係、技術轉移協議以及區域性監管策略對於駕馭這種多元化的市場環境，並使產品系列與區域臨床和經濟優先事項保持一致至關重要。

膜式氧合器供應商之間的競爭與夥伴關係動態，重點在於材料創新、智慧財產權定位、生產規模化與服務差異化。

膜式氧合器的競爭格局由純粹的製造商、大型醫療設備原始設備製造商 (OEM) 和靈活的契約製造共同構成。市場領導和創新新參與企業都在投資研發能夠降低血栓形成反應的塗層化學技術、能夠延長功能持續時間的膜材料以及能夠提高批次間一致性的生產過程。設備設計方與臨床研究中心之間的策略夥伴關係加速了實證醫學證據的產生，而與契約製造製造商和包裝專家的合作則有助於更快地擴大生產規模並拓展地域覆蓋範圍。

中空纖維幾何結構、表面處理流程和整合感測器技術的智慧財產權組合仍然是戰略資產，而那些將強大的智慧財產權保護與清晰的臨床價值主張提案結合的公司往往能夠獲得有利的採購結果。銷售策略各不相同，一些公司強調與醫院建立直接聯繫和進行臨床培訓項目，而另一些公司則利用分銷商網路實現廣泛應用。對於許多製藥公司而言，下一波差異化浪潮將來自於展現強大的實際臨床表現、提供綜合臨床支援服務以及在關鍵司法管轄區展現清晰的合規路徑。

為高階主管提供切實可行的優先行動方案，以加強供應鏈、加速材料創新、實現平台模組化並深化臨床夥伴關係，進而推動永續應用。

產業領導者必須在多個方面採取行動，以贏得臨床信任、保障淨利率並確保供應的連續性。首先，應優先考慮供應商多元化和盡可能選擇近岸外包，以降低進口關稅和物流波動帶來的風險。其次，應加快對聚甲基戊烯加工能力和有效表面處理技術的投資，以顯著降低血液相容性風險。第三，應在產品系列設計中融入模組化概念，使同一核心氧氣濃縮機平台能夠滿足不同的應用場景，例如冠狀動脈冠狀動脈繞道手術移植術、瓣膜置換術、靜脈-動脈體外膜氧合（VA-ECMO）和靜脈體外膜肺氧合（VECMO）。

此外，我們將透過結構化的培訓計畫和以結果為導向的支援服務，擴大臨床參與度，以減少在門診手術中心和社區醫院實施過程中遇到的阻力。我們將積極與監管機構溝通，使臨床證據的產生與核准途徑保持一致，並預測無菌性和標籤要求的變化。最後，在貿易政策和報銷預期不斷變化的環境下，我們將透過強調與採購方進行透明的整體使用成本溝通，並著重於設備的可靠性、生命週期物流和上市後支持，來建立長期的採購關係。

技術和商業性洞察透過嚴謹的多模態調查方法檢驗，該方法結合了專家訪談、臨床文獻綜述、法規分析和供應商分析。

該調查方法基於多層級研究方法，旨在確保研究結果的可重複性、臨床有效性和商業性適用性。主要研究內容包括對臨床醫生、灌注師、採購專業人員和生產負責人進行結構化訪談，以了解實際應用中的性能預期、採購限制和營運考慮。次要研究整合了同行評審的臨床文獻、監管文件、設備標籤、專利系列和標準指南，以檢驗技術聲明並建立基準性能標準。供應商分佈圖和生產能力評估結合了公共資源、行業名錄和現場訊息，以確定產能限制和區域生產佈局。

此分析方法著重於三角驗證，即從臨床洞察中解讀技術規範，並將其與生產可行性和監管先例進行配對。細分分析利用檢驗的臨床工作流程和採購行為，將定性需求促進因素分配給設備類型、應用、終端用戶、材料、流程配置和溫度通訊協定。其局限性包括各國採購慣例的差異和不斷變化的貿易政策，調查方法透過基於情境的敏感性檢查和專家檢驗來解決這些問題。訪談過程中遵循了倫理審查程序和保密措施，以保護專有臨床數據並確保符合研究管治規範。

整合臨床、技術、監管和供應鏈優先事項的策略結論，指導膜氧氣療法領域做出具有韌性、以臨床為中心的決策。

最後，膜式氧合器處於臨床表現、材料工程和供應鏈策略的關鍵交匯點。設計選擇，特別是膜結構、聚合物選擇和表面化學的選擇，直接影響心肺體外迴圈、體外膜氧合和研究應用的臨床結果。監管預期、臨床中心分散化和新興貿易政策的相互作用，要求相關人員採取靈活的籌資策略、有針對性的臨床證據產生和產品模組化設計，以保持競爭力。

決策者應優先考慮兼顧材料創新和可製造性的投資，同時重視臨床醫師使用便利性和上市後監測。區域策略應根據當前的監管和採購環境進行調整，而那些兼具卓越技術能力和服務交付能力的公司將更有利於獲得長期的臨床認可。透過整合本文概述的策略、臨床和營運方面的見解，產業參與者可以應對短期挑戰，同時推進更安全、更有效的氧氣輸送解決方案，造福病患。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 開發生物活性肝素結合聚合物膜以降低體外生命維持中的血栓形成風險
  • 整合即時感測器陣列和人工智慧驅動的分析技術，用於預測薄膜性能
  • 用於現場急救的攜帶式體外循環裝置和膜式氧合器的微型化
  • 利用3D列印技術製備聚甲基戊烯膜以實現客製化流動動力學的研究進展
  • 監管協調旨在使長期體外膜氧合（ECMO）設備能夠支持患者數週的治療。
  • 兒科專用低預充氧合器設計的出現旨在最大限度減少新生兒護理中的血液稀釋
  • 利用釋放一氧化氮的聚合物實現無肝素表面塗層，以提高生物相容性

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章 膜式氧合器市場（按類型分類）

  • 平板
  • 中空纖維

9. 按應用分類的薄膜式氧合器市場

  • 血液氧合研究
    • 動物實驗
    • 體外研究
  • 心肺體外迴圈
    • 冠狀動脈繞道手術手術
    • 瓣膜置換手術
  • 體外膜氧合器
    • 靜脈-動脈體外膜氧合（ECMO）
    • 靜脈體外膜氧合（ECMO）

第10章 依最終用戶分類的薄膜式氧合器市場

  • 門診手術中心
  • 醫院
  • 研究所

第11章 膜式氧合器市場（依材料分類）

  • 聚甲基戊烯
  • 聚丙烯
  • 聚碸

第12章 依流量組合分類的薄膜式氧合器市場

  • 封閉式
  • 打開

第13章 依溫度分類的薄膜式氧合器市場

  • 低溫
  • 正常體溫

第14章 膜式氧合器市場（依地區分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 膜式氧合器市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國膜式氧合器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Getinge AB
    • Medtronic PLC
    • LivaNova PLC
    • Terumo Corporation
    • Fresenius Medical Care AG & Co. KGaA
    • Merck KGaA
    • Nipro Corporation
    • Asahi Kasei Medical Co., Ltd.
    • Xenios AG
    • Nikkiso Co., Ltd.
Product Code: MRR-3E7F10ED1B0D

The Membrane Oxygenators Market is projected to grow by USD 1,114.33 million at a CAGR of 6.77% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 659.81 million
Estimated Year [2025] USD 704.16 million
Forecast Year [2032] USD 1,114.33 million
CAGR (%) 6.77%

A comprehensive orientation to membrane oxygenators that frames clinical imperatives, technological underpinnings, regulatory pressures, and strategic priorities for industry stakeholders

Membrane oxygenators are a foundational technology in extracorporeal life support and surgical perfusion, serving as the blood-gas exchange interface that sustains oxygenation and carbon dioxide removal during cardiopulmonary bypass procedures and prolonged extracorporeal membrane oxygenation. Their design, materials, and integration with monitoring systems determine not only clinical performance but also disposability, biocompatibility, and ease of use in high-acuity settings. As clinical practice evolves toward more complex critical care applications and ambulatory surgical interventions, oxygenator reliability and predictability remain pivotal to patient outcomes.

Increasingly, clinicians demand devices that balance physiologic performance with operational efficiency. This has driven parallel developments in membrane geometry, fiber fabrication, and surface chemistry to reduce hemolysis, complement activation, and thrombogenicity while maintaining low transmembrane pressure gradients. At the same time, regulatory expectations for single-use devices, sterilization validation, and human factors engineering have sharpened product development priorities. Taken together, these technical and clinical drivers frame the remainder of this executive summary and set the stage for strategic decisions across manufacturing, procurement, and clinical adoption.

How material innovations, device miniaturization, digital integration, and decentralized clinical practice are redefining design, manufacturing, and procurement standards in membrane oxygenation

The membrane oxygenator landscape has undergone transformative shifts driven by clinical need, materials science, and systems integration. Hollow fiber architectures, coupled with advanced polymethylpentene membranes and refined surface coatings, have largely supplanted earlier flat sheet approaches for high-performance extracorporeal support, yielding improvements in gas transfer efficiency and hemocompatibility. Parallel advances in manufacturing fidelity and sterilization processes have enabled scaled production of single-use oxygenators that meet stringent sterility and traceability expectations, while also simplifying operating room logistics.

Concurrently, the clinical environment for these devices is decentralizing. Increased use of extracorporeal membrane oxygenation in nontraditional settings, expansion of ambulatory surgical centers performing complex procedures, and greater reliance on simulation and point-of-care diagnostics have shifted demand toward more modular, user-friendly devices with integrated monitoring. Digital health integration-including real-time sensor telemetry and decision-support algorithms-has enhanced clinician ability to titrate therapy and preempt complications. Sustainability has emerged as a secondary yet growing priority, prompting manufacturers to evaluate lifecycle impacts and to explore recyclable packaging, reduced material footprints, and production waste reduction. Together, these shifts are reshaping development roadmaps, go-to-market strategies, and the criteria by which purchasers evaluate product value.

Analyzing the cumulative supply chain, procurement, and innovation consequences of United States tariff adjustments anticipated in 2025 for membrane oxygenator stakeholders

Anticipated trade policy changes and tariff adjustments in the United States during 2025 carry important implications for membrane oxygenator supply chains, procurement strategies, and price dynamics. Many oxygenator components and high-precision manufacturing inputs originate in cross-border supply chains, and increased duties on imported raw materials, polymer resins, or finished components may elevate landed costs for manufacturers and downstream purchasers. This shift tends to incentivize both suppliers and OEMs to reassess sourcing strategies, accelerate supplier qualification for domestic or nearshore partners, and consider localized inventory buffers to maintain continuity of supply under fluctuating trade conditions.

The cumulative effect of tariff-driven cost pressures often manifests through slower new product introductions and more conservative inventory management in the near term, as manufacturers prioritize margin protection and supply stability. In response, several mitigation pathways are practicable: diversifying the supplier base to reduce single-source exposure; qualifying alternate materials that preserve clinical performance while improving tariff treatment; and implementing contract manufacturing agreements in tariff-favored jurisdictions. For purchasers, longer procurement lead times and revised total-cost-of-ownership calculations will require renewed emphasis on supplier transparency and collaborative forecasting. Ultimately, trade policy is accelerating strategic decisions around vertical integration, supplier partnerships, and design choices that can reduce vulnerability to import duties while sustaining clinical performance standards.

Segmentation-driven insights that reveal how device architecture, clinical application, end-user priorities, material science, flow configuration, and thermal protocols intersect to inform product strategy

Insightful segmentation clarifies how product features, clinical use cases, and organizational purchasing priorities intersect to shape demand and innovation pathways. Based on Type, the market is studied across Flat Sheet and Hollow Fiber architectures; flat sheet designs retain niche applicability for certain bench research and specialized low-flow scenarios, while hollow fiber constructs dominate clinical extracorporeal applications where surface-area-to-volume efficiency and compact form factor matter. In application contexts, the market is studied across Blood Oxygenation For Research, Cardiopulmonary Bypass, and Extracorporeal Membrane Oxygenation. Blood Oxygenation For Research is further studied across Animal Studies and In Vitro Studies, which drive material testing and preclinical performance validation; Cardiopulmonary Bypass is further studied across Coronary Artery Bypass Grafting and Valve Replacement Surgery, both of which impose distinct perfusion time profiles and anticoagulation management challenges; and Extracorporeal Membrane Oxygenation is further studied across Venoarterial ECMO and Venovenous ECMO, reflecting divergent hemodynamic and oxygenation requirements that influence membrane selection and flow architecture.

End user segmentation reveals differing procurement drivers: Ambulatory Surgical Centers, Hospitals, and Research Institutes each evaluate oxygenators through lenses of cost efficiency, clinical robustness, and experimental flexibility, respectively. Based on Material, the market is studied across Polymethylpentene, Polypropylene, and Polysulfone, with polymethylpentene increasingly preferred for long-duration extracorporeal support due to its favorable gas permeability and thermal stability, while polypropylene offers cost advantages in some disposable formats and polysulfone provides broad thermal and chemical resilience. Flow configuration analysis, based on Flow Configuration, examines Closed and Open systems, where closed-loop designs prioritize infection control and precise gas exchange control and open configurations favor simplicity and accessibility for certain surgical workflows. Temperature-driven segmentation, based on Temperature, studies Hypothermic and Normothermic use cases, recognizing that membrane performance and hemocompatibility profiles can differ under altered thermal states and that device validation must address biophysical variability across these clinical protocols. Collectively, these segmentation lenses inform design trade-offs, regulatory strategies, and targeted commercialization approaches.

Regional clinical adoption, regulatory diversity, and manufacturing capacity shape differentiated strategies across the Americas, EMEA, and Asia-Pacific markets for membrane oxygenator businesses

Regional variation influences clinical practices, regulatory pathways, and procurement frameworks in ways that matter for manufacturers and health systems alike. In the Americas, clinical adoption is shaped by concentrated centers of excellence for extracorporeal therapy, a regulatory environment that emphasizes post-market surveillance and device traceability, and supply chains that favor both domestic manufacturing and strategic imports. These dynamics create opportunities for companies that can demonstrate robust clinical data, scalable manufacturing, and responsive service models.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with country-specific procurement norms; reimbursement variability and divergent hospital tender processes require flexible commercialization models and strong clinical affairs engagement. Local manufacturing partnerships and distributor relationships frequently determine market entry speed. Asia-Pacific continues to exhibit rapid clinical adoption in selected urban centers, coupled with an expanding base of local manufacturers and contract producers capable of competing on lead time and cost. Strategic partnerships, technology transfer agreements, and region-specific regulatory strategies are essential to navigate this diverse territory and to align product portfolios with regional clinical and economic priorities.

Competitive and partnership dynamics that highlight material innovation, IP positioning, manufacturing scaling, and service-enabled differentiation among membrane oxygenator providers

Competitive dynamics in the membrane oxygenator landscape are defined by a blend of specialized manufacturers, large medical device OEMs, and nimble contract producers. Market leaders and innovative newcomers alike are investing in coating chemistries that reduce thrombogenic response, in membrane materials that extend functional duration, and in manufacturing processes that improve lot-to-lot consistency. Strategic partnerships between device designers and clinical research centers are accelerating evidence generation, while alliances with contract manufacturers and packaging specialists are enabling faster scale-up and broader geographic reach.

Intellectual property portfolios around hollow fiber geometry, surface treatment processes, and integrated sensor technologies remain strategic assets, and companies that combine strong IP protection with a clear clinical value proposition tend to secure favorable procurement outcomes. Distribution strategies vary, with some firms emphasizing direct hospital relationships and clinical training programs, while others leverage distributor networks to broaden penetration. For many players, the next wave of differentiation will come from demonstrating superior real-world performance, offering integrated clinical support services, and presenting clear pathways for regulatory compliance in key jurisdictions.

Practical and prioritized actions for executives to fortify supply chains, accelerate material innovation, modularize platforms, and deepen clinical partnerships to drive sustainable adoption

Industry leaders must adopt a multi-pronged set of actions to capture clinical trust, protect margins, and ensure supply continuity. First, prioritize supplier diversification and nearshoring where feasible to reduce exposure to import duties and logistics volatility; dual-sourcing critical inputs and qualifying alternate polymer suppliers will materially improve resilience. Second, accelerate investment in polymethylpentene processing capabilities and in validated surface treatments that demonstrably reduce hemocompatibility risks, since these attributes increasingly inform purchasing decisions among perfusionists and critical care teams. Third, design product portfolios with modularity in mind, enabling the same core oxygenator platform to address distinct use cases-such as coronary artery bypass grafting, valve replacement surgery, venoarterial ECMO, and venovenous ECMO-through targeted configurators and accessory kits.

Additionally, expand clinical engagement through structured training programs and outcome-oriented support services that reduce adoption friction in ambulatory surgical centers and community hospitals. Engage proactively with regulatory bodies to align clinical evidence generation with approval pathways and to anticipate changes in sterility and labeling requirements. Finally, adopt transparent total-cost-of-use communication with purchasers, emphasizing device reliability, lifecycle logistics, and post-market support to build durable procurement relationships in an environment of evolving trade policy and reimbursement expectations.

A rigorous multimodal research methodology combining expert interviews, clinical literature review, regulatory analysis, and supplier mapping to validate technical and commercial insights

This research draws on a layered methodology designed to ensure reproducibility, clinical relevance, and commercial applicability. Primary inputs include structured interviews with clinicians, perfusionists, procurement professionals, and manufacturing leaders to capture real-world performance expectations, procurement constraints, and operational considerations. Secondary research synthesizes peer-reviewed clinical literature, regulatory filings, device labeling, patent families, and standards guidance to validate technological claims and to establish baseline performance criteria. Supplier mapping and manufacturing capability assessments combine public filings, industry directories, and site-level intelligence to identify capacity constraints and regional production footprints.

Analytical methods emphasize triangulation: clinical insights inform interpretation of technical specifications, which are then cross-checked against manufacturing feasibility and regulatory precedent. Segmentation analysis uses validated clinical workflows and procurement behaviors to allocate qualitative demand drivers across device types, applications, end users, materials, flow configurations, and temperature protocols. Limitations include variability in country-level procurement practices and the evolving nature of trade policy, which the methodology addresses through scenario-based sensitivity checks and expert validation rounds. Ethical review procedures and confidentiality safeguards were applied during interviews to protect proprietary clinical data and to ensure compliance with research governance norms.

Strategic conclusions synthesizing clinical, technical, regulatory, and supply chain priorities to guide resilient and clinically focused decision-making in membrane oxygenation

In closing, membrane oxygenators occupy a critical nexus of clinical performance, materials engineering, and supply chain strategy. Design choices-particularly around membrane architecture, polymer selection, and surface chemistry-directly influence clinical outcomes across cardiopulmonary bypass, extracorporeal membrane oxygenation, and research applications. The interplay between regulatory expectations, decentralizing clinical settings, and emergent trade policies requires stakeholders to pursue resilient sourcing strategies, targeted clinical evidence generation, and product modularity to remain competitive.

Decision-makers should prioritize investments that align material innovation with manufacturability, while maintaining a sharp focus on clinician usability and post-market surveillance. Regional strategies must be tailored to prevailing regulatory and procurement landscapes, and companies that combine technical excellence with service-enabled offerings will be better positioned to capture long-term clinical trust. By integrating the strategic, clinical, and operational insights outlined here, industry participants can navigate near-term disruptions while advancing safer, more effective oxygenation solutions for patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of bioactive heparin-bonded polymer membranes to reduce clotting risk in extracorporeal life support
  • 5.2. Integration of real-time sensor arrays and AI-driven analytics for predictive membrane performance monitoring
  • 5.3. Miniaturization of portable extracorporeal membrane oxygenators for in-field emergency applications
  • 5.4. Advancements in polymethylpentene membrane manufacturing using 3D printing for customized flow dynamics
  • 5.5. Regulatory alignment for extended duration ECMO devices supporting multi-week patient therapies
  • 5.6. Emergence of pediatric-specific low-prime oxygenator designs to minimize hemodilution in neonatal care
  • 5.7. Implementation of heparin-free surface coatings utilizing nitric oxide-releasing polymers to enhance biocompatibility

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Membrane Oxygenators Market, by Type

  • 8.1. Flat Sheet
  • 8.2. Hollow Fiber

9. Membrane Oxygenators Market, by Application

  • 9.1. Blood Oxygenation For Research
    • 9.1.1. Animal Studies
    • 9.1.2. In Vitro Studies
  • 9.2. Cardiopulmonary Bypass
    • 9.2.1. Coronary Artery Bypass Grafting
    • 9.2.2. Valve Replacement Surgery
  • 9.3. Extracorporeal Membrane Oxygenation
    • 9.3.1. Venoarterial ECMO
    • 9.3.2. Venovenous ECMO

10. Membrane Oxygenators Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Research Institutes

11. Membrane Oxygenators Market, by Material

  • 11.1. Polymethylpentene
  • 11.2. Polypropylene
  • 11.3. Polysulfone

12. Membrane Oxygenators Market, by Flow Configuration

  • 12.1. Closed
  • 12.2. Open

13. Membrane Oxygenators Market, by Temperature

  • 13.1. Hypothermic
  • 13.2. Normothermic

14. Membrane Oxygenators Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Membrane Oxygenators Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Membrane Oxygenators Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Getinge AB
    • 17.3.2. Medtronic PLC
    • 17.3.3. LivaNova PLC
    • 17.3.4. Terumo Corporation
    • 17.3.5. Fresenius Medical Care AG & Co. KGaA
    • 17.3.6. Merck KGaA
    • 17.3.7. Nipro Corporation
    • 17.3.8. Asahi Kasei Medical Co., Ltd.
    • 17.3.9. Xenios AG
    • 17.3.10. Nikkiso Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. MEMBRANE OXYGENATORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. MEMBRANE OXYGENATORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEMBRANE OXYGENATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLAT SHEET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN MEMB